CTRI/2017/07/008984招募中4 期
The efficacy of a combination of Tamsulosin and Solifenacin versus Tamsulosin alone in patients with Benign Prostatic Hypertrophy with Overactive Bladder Symptoms
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Lower Urinary Tract Symptoms for more than 3 months, that are
- •Attributable to Benign Prostatic Hyperplasia (BPH), as confirmed with
- •International Prostate Symptom Score of greater than 8, and who have
- •Maximum urine flow rate of less than 12 ml/second, with voided volume more than 120 ml and
- •Post-void residue measured by Ultrasound (USG) of less than 120 ml,
- •Overactive bladder symptoms of more than 8 voids in 24 hours, more than 2 voids at night, and more than 1 episode of urgency in 24 hours
排除标准
- •Urinary retention in preceding 12 months, or
- •Treatment of BPH with alpha-receptor antagonists, plant extracts, and or 5-alpha-reductase inhibitors, or
- •Other causes of LUTS e.g., urethral stricture, or
- •Neurogenic bladder
研究者
相似试验
已完成
不适用
Effect of tamsulosin and minirin in treatment of BPHBenign Prostatic Hyperplasia.Hyperplasia of prostateIRCT201205219819N1rologyResearch Center354
已完成
不适用
Role of alpha blocker and steroid in better and early clearance of kidney and ureteric stones after extracorporeal lithotripsyCTRI/2018/04/013187SIR GANGA RAM HOSPITA143
已完成
不适用
A clinical trail to study the effects of alpha blocker tamsulosin and drug combination alpha blocker tamsulosin and competitive muscarinic-receptor antagonist solifenacin in treatment with ureteral stent related lower urinary tract symptoms.CTRI/2020/04/024945ankit100
尚未招募
Unknown
ALPHABET studyOveractive bladder with benign prostatic hyperplasiaOAB BPHJPRN-jRCT1011230058Wada Naoki60
已完成
3 期
The effect of Tamsulosin and Solifenacin in the treatment of double J stent-related urinary symptomsIRCT20200831048564N1Mashhad University of Medical Sciences80